PBIO redesigned its UST Technology Platform to be used in
PBIO redesigned its UST Technology Platform to be used in the CBD beverage industry. This new technology called the BaroShear K45 has been specifically designed to meet all of the specifications required for the efficient processing of CBD oil into a completely water soluble end product to be used in the CBD infused beverage industry. The BaroShear K45 is a unique and powerful next generation nanoemulsification system that uses the company's UST Ultra Sheer Technology Platform to process CBD oil in a cost effective manner without the use of harmful and expensive chemicals. This scientific breakthrough will be marketed to CBD infused beverage companies and CBD oil processing companies located around the globe. The company already has worldwide sales and distribution channels in place to market and service the BaroShear K45. The company has put collaboration agreements together with several CBD industry veterans leading to strategic partnership opportunities that further benefit the company's research and development efforts. The company's superior CBD end product gives the company a huge branding opportunity that can possibly lead to very substantial contracts and joint venture licensing deals.
The company's BaroShear K45 product launch couldn't have come at a more opportune time in the CBD industry's history. With the passage of the 2018 Farm Bill, entrepreneurs are rushing to grow hemp and extract CBD oil that is water soluble and safe for sale to individual consumers or as an ingredient that is infused into beverages. Projected revenue for CBD infused beverages alone is expected to be $220 million by 2022.
The company recently projected this years revenue to double from $2.5 million to $5 million as a result of the high demand expected for the company's BaroShear K45 technology. Technology companies with 100% growth rates can easily trade at upwards of 10 times annual sales which could realistically lead to a $50 million valuation for the company's stock. With less than 2 million shares outstanding the stock may move significantly higher from current levels in the near term as the current market capitalization is a miniscule $5.9 million offering a substantial upside to the company's shares. Trading at only 1.2 times this years forecasted sales PBIO is a very cheap stock compared with its CBD industry peers. The company previously traded on the NASDAQ for upwards of $18.00. The CBD market is hot and valuations are soaring. PBIO is a great way to add the extraordinary growth of the CBD sector to your portfolio.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Fresh Perspective on Portable Projection If anyone had told me a tech brand would buddy up with the world of fine art to launch a new gadget line, I'd have raised an eyebrow. But here we are, shrugging away the standard and looking at what's cooking over at Aurzen. The company's new initiative, 'Unfold the Art,' marries the magnetism of Jean-Michel Basquiat's artwork...
Continue Reading
A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...
Continue Reading
Rodeo Dental's Leadership Shuffle When you're talking about upping the ante in the dental world, you can't ignore the recent shake-up at Rodeo Dental & Orthodontics. They've decided to retool their corner office lineup, and this is where the folks in suits meet the folks with the steady hands in teeth. Co-Founder Dr. Saam Zarrabi is stepping into an Executive Chairman...
Continue Reading
Transamerica's Next Phase: Leadership Moves in Retirement Transamerica just pulled a move that’s both bold and calculated. They’ve beefed up their retirement distribution squad with Danny Kling and Kevin Murphy stepping into the spotlight. These guys are bringing heaps of experience and a fresh jolt of energy to keep the momentum going. No doubt this is Transamerica...
Continue Reading
Community Aid Amid Rising Costs In a city notorious for its hustle, ensuring families have what they need to thrive is no small feat. Recently, over 1,000 New Yorkers flocked to a health and wellness fair held by Public Health Solutions (PHS) and ModifyHealth. These committed folks joined forces in Harlem to bring some much-needed stability to local families as living...
Continue Reading
Passing the Baton in BRP's Financial Helm Alright, folks, grab your coffee and listen up. There's a shakeup coming from the cold corners of Valcourt, Quebec—BRP Inc., the powersports behemoth on the TSX: DOO, has announced a changing of the guard in their finance department. Come October 1st, there's a planned power shift as Sébastien Martel steps down as CFO, passing...
Continue Reading
What's Cooking at Hotel Zetta? Ever see a company shake up an event like TELUS Digital is about to at Dreamforce 2026? Instead of the usual booth schmooze-fest at Moscone Center, these folks are camping at Hotel Zetta with a packed 'boutique' agenda. From September 15–16, they're rolling out serious insider sessions for the big brains in financial services, education,...
Continue Reading
California's Lincoln Oaks neighborhood is gearing up for some necessary upheaval, thanks to California American Water’s new $8.6 million infrastructure overhaul. For decades, those folks in Sylvan Park have been juggling with the roulette of aging water mains in their backyards. Now, imagine that: backyard pipes begging to turn traitors. It's about time someone decided...
Continue Reading
Revolutionizing Safety in the Workplace Cracking the typical mindset of treating employee safety as a checkbox item, Debra Wein, CEO and Founder of Wellness Workdays, is set to shake up the NSC Safety Congress & Expo. Her upcoming session, titled "Transforming Safety and Wellbeing into a Competitive Business Advantage," isn't just a run-of-the-mill talk. It's a call to...
Continue Reading
DeFi Must Step Up To Meet Compliance Challenge Alright, folks, here's the scoop: DeFi Technologies just picked up another 180 days from Nasdaq to get its act together and hit that crucial one-buck minimum bid price. It's like getting extra time on a pop quiz you forgot to study for—useful, but no guarantee they'll pass. What Led to the Extra Time? These guys over at...
Continue Reading
Top 5 Most Recently Viewed Articles
Ascend Wellness Holdings Financial Highlights AWH experienced significant growth with a reported net revenue of $562 million in the fiscal year, reflecting an 8% year-on-year increase. This growth highlights the company’s resilience and strategic direction in the evolving cannabis landscape. Positive Operational Metrics With adjustments made to enhance efficiency, AWH...
Continue Reading
Innovative Partnership Announced in Memphis The National Civil Rights Museum and Unite Memphis have joined forces to promote a powerful message rooted in healing, honor, and hope within the vibrant city of Memphis. This partnership marks a pivotal moment for Unite Memphis, which has impressively grown by 43% in participation last year as it enters its fourth anniversary....
Continue Reading
Ohio Paves New Paths in Anesthesia Care With a flick of the pen, Ohio made a significant change in its healthcare landscape, opting out of physician supervision requirements for Certified Registered Nurse Anesthetists (CRNAs). Governor Mike DeWine's decision marks Ohio as the 27th state to liberate CRNAs from an outdated mandate. This isn’t your typical shuffle of the...
Continue Reading
Infosys and Google Cloud Collaboration Overview Infosys (NYSE: INFY), renowned for its next-generation digital services, has announced a groundbreaking collaboration with Google Cloud, creating a center of excellence dedicated to enterprise AI innovation. This initiative will leverage cutting-edge technologies, particularly Infosys Topaz, to develop transformative...
Continue Reading
Nucleome Therapeutics just dropped a bombshell with the appointment of Dr. Michelle Morrow as their Chief Scientific Officer. This move could be a game changer, considering her hefty background in immunology and drug development. Dr. Morrow isn't just a fresh face; she's packing twenty years of experience under her belt, primarily shaping drug discovery strategies at...
Continue Reading